Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

SciTree Final Presentation


Published on

Published in: Business, Technology
  • Be the first to comment

  • Be the first to like this

SciTree Final Presentation

  1. 1. Final Team Presentationfor Venture LabKalmykova E and Viaña JNM
  2. 2. Elena Kalmykova John Noel M. ViañaWhy we do this?
  3. 3. New technologies (materials, Scientific networks have no contactsubstances, technique) are a basis or crossing with investors’of contemporary economy and an networks.ideal target for investment.Science produces plenty of new Scientific Output comes in form oftechnologies, which can be verbose papers, inaccessible andconverted into business product, incomprehensible for peopleand create revenue. outside of academy.However investors do not havedirect access to information about Investors’ Input comes in form ofnew technologies worldwide. It simple and short presentations andespecially concerns cutting edge business plans, which scientists aretechnologies, produced in the not used to make.third-world countries. This results in a gap The organizations mediating between Science and partnerships between science and business, between new business work with European and technologies and their American scientists, neglecting implementation to solve technology from lesser-known real world problems. regions and developing countries.Problem Reasons
  4. 4. SciTree A web platform for collaboration between scientists and investors• Changing scientific Output :short statementabout new technology (150 words)+ link to apaper. As our surveys have shown, it’s thebest format for scientists and investors.• Investors can find an expertise for newtechnologies, look for a technology they wantto turn into a product, buy patents• Big companies can find a research group forhiring and investment•We provide brokering between scientists andinvestors• Constant monitoring of new technologiesSolution
  5. 5. Over 5 million scientists are developing new technologies (biology, medicine, materials, etc). Scientists get financing by writing articles for peer-review journals and project proposals for research funds (government organizations), which takes up to 50% of their working time. This is ineffective usage of their time and brainpower. Companies spend up to 43% of revenue on R&D (Allergan – 43.4%, Eriksson – 24.9%). New technologies are important for progress and successful competition. Big companies are hunting for new technologies. But they miss all perspective and groundbreaking technologies from the third world, as there are no platforms giving access to these technologies.Market With SciTree, entire Science can be used as your own R&D department. Outsource your Research and Development globally.
  6. 6. •Research groups and scientists in the academeKey Partnerships •Investment firms and investors •Science and technology-oriented companies •Creation and maintenance of SciTree’s website •Establishment of contacts and registered users Key Activities from the industry and academe •Networking with Investors, S&T companies •Web hosting, CMS, database Key Resources •Contacts both in the industry and academe •Network of investors and scientists •Resource personnel and Technical staff •Environment for interdisciplinary scientific work and direct communication with investors and S&T companies Value •Problem-based organization of Science research •Venue for outlicensing patented technologies and Propositions brokering of academe-industry partnerships (Non- Disclosure Agreements) •Updates from scientists from all around the world •Concise, brief, and reputable Science newsBusiness Model
  7. 7. Customer •Correspondence (e-mail, written letters) with scientists, investors, and companiesRelationships •Featuring cases of successful partnerships • Internet; flyers and brochures; booths in scientific conferences; direct contact with universities and Channels Technological Transfer Offices; communication (direct or e-mail dropshots) with investors and S&T companies Customer •Scientists and Academics looking for external funding Segments •Investors and S&T companies looking to outsource patented technologies and collaborate with the academe •Web hosting, site design, and database managementCost Structure •Advertisements and marketing in scientific conferences •Recruitment of skilled professionals and technical staff •Participation fees in actual networking events •Targeted advertising (Google Ads) Revenue •Membership and monthly subscription fees to investor- Streams specific Science news and updates •Brokering of academe and industry partnershipsBusiness Model
  8. 8. Investors:pay for subscription (golden and Advertising: targeted ads silver membership), exclusive(lab equipment, laptops etc) access to database of patents and community of experts Investors: pay for review of dynamics of fieldScientists: pay to promote development, analytics, your news or team consulting and selection of teams for investment Brokering of partnerships Universities: pay for between scientists and advertising academic jobs investorsMarketing
  9. 9. Risks Funding• Lack of interest of customers to SciTree 1. Large foundations that Strategy: Keeping track of user opinions support scientific structure regarding SciTree and applying them development efforts• Failure of Online Brokering 2. International Grant-giving Strategy: Focus on Other Revenue Streams Agencies (European FP7 Capacities programme)• Competitors copying or simulating 3. Individuals (venture features unique to SciTree capitalists, business Strategy: Improve our proposition to the customers and improve service angels)Social network for scientists, Social network for A consultancy firm,1.7 million users. scientists, 1.8 million Deficiencies: high price,Deficiencies: scientists only, users. Deficiencies: lack of transparency, lackoutput in a form of big scientists only, output in of direct contacts witharticles. a form of big articles. scientists, no third-world technologies.Competitors
  10. 10. Dr. Reynaldo Garcia, mentorProfessor of Molecular Biology and Biotechnology at University of the Philippines DilimanDirector, Technology Transfer and Business Development Office at University of the Philippines.Has experience working as UK Biotech Consultant/Business Intelligence Provider at FreelanceBioscience Key Account Manager at London Biotechnology Network SystemDr. Elena Kalmykova, CEOPhD in Philosophy (Uppsala University, Sweden). Graduated from Oriental and PhilosophyFaculties at Saint-Petersburg State University.Courses attended: Technology Entrepreneurship (Stanford University), Researchers andLeadership (Swedish Institute). Published over 20 papers on the topics such as structure ofscientific knowledge and communication in science.Work experience in web-projects: Electric Jungle (Sun Microsystems), SMM, web design,member of Wallenberg Calendar team.John Noel M. Viaña, CMOBS in Molecular Biology and Biotechnology (University of the Philippines - Diliman).Has worked at the Laboratory of Molecular and Cell Biology at the National Institute of MolecularBiology and Biotechnology, UP DilimanMember of international honor societies (Phi Kappa Phi and Phi Sigma Biological Sciences HonorSociety). Courses attended: Technological Entrepreneurship at Stanford’s Venture Lab.Syrgak Turgumbaev, CTOBS in Computer Science (Kyrgyz State Technical University)Has 4 year work experience as software developer at Xponaut AB, Sweden and 2.5 year experienceas web consultant at ModularStreams Sweden AB. Working with Drupal, PHP, Flex, CSS3, HTML5,programming language: C++. Team